Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome After Alemtuzumab or Basiliximab Induction

Journal of Immunology Research - Egypt
doi 10.1155/2015/985460
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Correction To: Basiliximab Versus Rabbit Antithymocyte Globulin as Induction Therapy for Living-Related Renal Transplantation: A Single-Center Experience

International Urology and Nephrology
UrologyNephrology
2019English

The Proteome of Small Urinary Extracellular Vesicles After Kidney Transplantation as an Indicator of Renal Cellular Biology and a Source for Markers Predicting Outcome

2019English

Poor Outcomes in Elderly Kidney Transplant Recipients Receiving Alemtuzumab Induction

American Journal of Nephrology
Nephrology
2011English

Left Ventricular Function Outcome After Coronary Artery Bypass Grafting, King Abdullah Medical City (KAMC)- Single-Center Experience

Egyptian Heart Journal
Cardiovascular MedicineCardiology
2019English

DCD Donor Hemodynamics as Predictor of Outcome After Kidney Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Outcome Prediction After Surgical Management of Prosthetic Mitral Valve Dysfunction; A Single Center Experience

The Egyptian Cardiothoracic Surgeon
2019English

Equivalence Outcome in Single Subjects as a Function of Training Structure

Psychological Record
ArtsPsychologyHumanities
2000English

Assessing the Likely Cost-Utility of Alemtuzumab Versus Rabbit Anti-Thymocte Globulin as Induction Therapy for High-Risk Kidney Transplant Recipients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Can Readmission Rates Be Used as an Outcome Indicator?

BMJ
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy